VireturnRevenue
3.1B USDAnnual · FY 2025WST
WEST PHARMACEUTICAL SERVICES INC
Operating income
584.9M USDAnnual · FY 2025Net income
493.7M USDAnnual · FY 2025Total assets
4.3B USDAnnual · FY 2025Equity
3.2B USDAnnual · FY 2025Operating cash flow
754.8M USDAnnual · FY 2025WST · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
3.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 2.8B USD |
| FY 2022 | 2.9B USD |
| FY 2023 | 2.9B USD |
| FY 2024 | 2.9B USD |
| FY 2025 | 3.1B USD |
Operating income
USD
584.9M USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 752.3M USD |
| FY 2022 | 734M USD |
| FY 2023 | 676M USD |
| FY 2024 | 569.9M USD |
| FY 2025 | 584.9M USD |
Net income
USD
493.7M USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 661.8M USD |
| FY 2022 | 585.9M USD |
| FY 2023 | 593.4M USD |
| FY 2024 | 492.7M USD |
| FY 2025 | 493.7M USD |
Total assets
USD
4.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 3.3B USD |
| FY 2022 | 3.6B USD |
| FY 2023 | 3.8B USD |
| FY 2024 | 3.6B USD |
| FY 2025 | 4.3B USD |
Equity
USD
3.2B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 2.3B USD |
| FY 2022 | 2.7B USD |
| FY 2023 | 2.9B USD |
| FY 2024 | 2.7B USD |
| FY 2025 | 3.2B USD |
Operating cash flow
USD
754.8M USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 584M USD |
| FY 2022 | 724M USD |
| FY 2023 | 776.5M USD |
| FY 2024 | 653.4M USD |
| FY 2025 | 754.8M USD |
Revenue growth
%
6.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | 31.9% |
| FY 2022 | 2% |
| FY 2023 | 2.2% |
| FY 2024 | -1.9% |
| FY 2025 | 6.3% |
Operating income growth
%
2.6%
Period data
| Period | Value |
|---|---|
| FY 2021 | 84.9% |
| FY 2022 | -2.4% |
| FY 2023 | -7.9% |
| FY 2024 | -15.7% |
| FY 2025 | 2.6% |
Net income growth
%
0.2%
Period data
| Period | Value |
|---|---|
| FY 2021 | 91.2% |
| FY 2022 | -11.5% |
| FY 2023 | 1.3% |
| FY 2024 | -17% |
| FY 2025 | 0.2% |
Operating margin
%
19%
Period data
| Period | Value |
|---|---|
| FY 2021 | 26.6% |
| FY 2022 | 25.4% |
| FY 2023 | 22.9% |
| FY 2024 | 19.7% |
| FY 2025 | 19% |
Net margin
%
16.1%
Period data
| Period | Value |
|---|---|
| FY 2021 | 23.4% |
| FY 2022 | 20.3% |
| FY 2023 | 20.1% |
| FY 2024 | 17% |
| FY 2025 | 16.1% |
Return on assets
%
12.5%
Period data
| Period | Value |
|---|---|
| FY 2021 | 21.7% |
| FY 2022 | 16.9% |
| FY 2023 | 15.9% |
| FY 2024 | 13.2% |
| FY 2025 | 12.5% |
Debt/Equity
x
0.34x
Period data
| Period | Value |
|---|---|
| FY 2021 | 0.42x |
| FY 2022 | 0.35x |
| FY 2023 | 0.33x |
| FY 2024 | 0.36x |
| FY 2025 | 0.34x |